InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
8
T+90 hit rate
67%
T+90 mean return
+7.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by CULLEN JAMES, Director. Officer active across 2 companies, notably Avinger Inc. Cumulatively, 14 disclosures have been logged. Split: 0 buy · 8 sells. Total volume traded: €4m. Activity tracked since 24 November 2021. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
3,000 shares@ US$346.58030.0016% mcap22.4% of flowCommon StockSEC:0001142630-26-000004:0
1,589 shares0Common StockSEC:0001601046-25-000025:0
1,632 shares0Common StockSEC:0001601046-24-000023:0
25,597 shares0Common StockSEC:0001437749-24-001520:0
4,869 shares@ US$146.468321.4% of flowCommon StockSEC:0001601046-23-000131:0
1,543 shares0Common StockSEC:0001601046-23-000036:0
60,976 shares0Common StockSEC:0001437749-23-001490:0
1,626 shares0Common StockSEC:0001601046-22-000026:0
7,000 shares@ US$196.450.0039% mcap50.0% of flowCommon StockSEC:0001601046-21-000194:0
7,000 shares@ US$196.4539.3% of flowCommon StockSEC:0001601046-21-000194
184 shares@ US$0.5742.0% of flowCommon StockSEC:0001437749-21-027580:0
184 shares@ US$0.5742.0% of flowCommon StockSEC:0001437749-21-027580
32 shares@ US$0.628.0% of flowCommon StockSEC:0001437749-21-027434:0
32 shares@ US$0.628.0% of flowCommon StockSEC:0001437749-21-027434
14 of 14 declarations
About CULLEN JAMES
James Cullen is a Director at Avinger Inc and Keysight Technologies, Inc. He plays a key role in the governance of these companies and in strategic decision-making. Avinger specializes in medical technologies, while Keysight Technologies is a leader in test and measurement solutions. James's experience is an asset to these organizations.
